Drug Description in Trials / DrugBank / KEGG DRUG
Search results
| No. | 薬物名（臨床試験情報から抽出） | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | 指定難病告示番号 |
|---|---|---|---|---|---|---|
| 1 | Other: Patients diagnosed with generalized myasthenia gravis and treated with Rozanolixizumab | 1件: Rozanolixizumab Rozanolixizumab (Rozanolixizumab) | 1件: Rozanolixizumab
Rozanolixizumab
(Rozanolixizumab, rozanolixizumab-noli) 💬
| - | - | 1件: 11 11 💬
|
| 2 | ROZANOLIXIZUMAB | 1件: Rozanolixizumab Rozanolixizumab (Rozanolixizumab) | 1件: Rozanolixizumab
Rozanolixizumab
(Rozanolixizumab, rozanolixizumab-noli) 💬
| - | - | 3件: 11 11, 14, 63 💬
|
| 3 | RozanolixizumabProduct Code: UCB7665Pharmaceutical Form: Solution for infusionINN or Proposed INN: ROZANOLIXIZUMABCAS Number: 1584645-37-3Current Sponsor code: UCB7665Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 140-Pharmaceutical form of the placebo: Solution for infusionRoute of administration of the placebo: Subcutaneous use | - | - | - | - | 1件: 63 63 💬
|